SCHEMBL39738

SCHEMBL39738

CCCCOCC(O)COc1ccc(-c2nc(-c3ccc(C)cc3C)nc(-c3ccc(C)cc3C)n2)c(O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 1/20 0.39
NPC1 O15118 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 3/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADRB2 P07550 4/20 0.36
ADRB1 P08588 2/20 0.36
SMN1; SMN2 Q16637 6/20 0.35
ACACB O00763 1/20 0.35
ACACA Q13085 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29497700 1.00 PLA2G4B (0.39) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL15721408 1.00 PLA2G4B (0.39) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL4625753 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL7524555 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL7704728 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL18231906 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL7925990 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL38700 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL31370 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A
SCHEMBL29349596 0.97 PLA2G4B (0.44) PLA2G4BNPC1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9543521-B2 Organic semiconductor device and process for its production BASF SE (DE) 2017-01-10 US claimed
US-20140306212-A1 ORGANIC SEMICONDUCTOR DEVICE AND PROCESS FOR ITS PRODUCTION BASF SE (DE) 2014-10-16 US claimed
EP-2780409-A1 ORGANIC SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2014-09-24 EP claimed
US-8664173-B2 Premoistened cleaning disposable substrate for leather and method of preserving a leather surface by contacting said surface with said substrate BASF SE (DE) 2014-03-04 US claimed
US-20130306151-A1 ORGANIC PHOTOVOLTAIC DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2013-11-21 US claimed
WO-2013072853-A1 ORGANIC SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF BASF SE (DE) 2013-05-23 WO claimed
EP-1310492-B1 Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers CYTEC TECH CORP (US) 2012-01-11 EP claimed
US-20080171683-A1 Premoistened cleaning disposable substrate for leather and method of preserving a leather surface by contacting said surface with said substrate BASF SE (DE) 2008-07-17 US claimed
EP-1298126-B1 Novel red-shifted triazine ultraviolet light absorbers CYTEC TECH CORP (US) 2008-03-05 EP claimed
EP-1680465-A1 UV STABILIZING ADDITIVE COMPOSITION CYTEC TECHNOLOGY CORP. (US) 2006-07-19 EP claimed
US-20030088098-A1 Novel red-shifted triazine ultravioletlight absorbers CYTEC TECHNOLOGY CORP. 2003-05-08 US claimed
WO-2003035733-A1 PROCESS FOR IMPROVING THE SHELF LIFE OF A HINDERED PHENOL ANTIOXIDANT CYTEC TECHNOLOGY CORP. (US) 2003-05-01 WO claimed
US-20030073771-A1 Process for improving the shelf life of a hindered phenol antioxidant CYTEC TECHNOLOGY CORP. 2003-04-17 US claimed
EP-1298126-A1 Novel red-shifted triazine ultraviolet light absorbers CYTEC TECHNOLOGY CORP. (US) 2003-04-02 EP claimed
US-20020161075-A1 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds CYTEC TECHNOLOGY CORP. 2002-10-31 US claimed
WO-2002046136-A2 BIS(ALKYLENEOXYBENZOPHENONE) ULTRAVIOLET LIGHT ABSORBERS CYTEC TECHNOLOGY CORP. (US) 2002-06-13 WO claimed
WO-2002036579-A1 NON-YELLOWING ORTHO-DIALKYL ARYL SUBSTITUTED TRIAZINE ULTRAVIOLET LIGHT ABSORBERS CYTEC TECHNOLOGY CORP. (US) 2002-05-10 WO claimed
US-6384113-B1 POLYMER STABILIZER; LOW VOLATILITY; WEATHERABILITY; YELLOWING RESISTANCE CYTEC TECHNOLOGY CORP. 2002-05-07 US claimed
US-20020028937-A1 Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers CYTEC TECHNOLOGY CORP. 2002-03-07 US claimed
US-6187919-B1 ULTRAVIOLET ABSORBERS CIBA SPECIALTY CHEMICALS CORPORATION 2001-02-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030088098-A1 Novel red-shifted triazine ultravioletlight absorbers SUN2, RAD52, XPO5 PLA2G4B 4852/4885NPC1 1412/4885ALDH1A1 573/4885
US-20020028937-A1 Benzocycle-substituted triazine and pyrimidine ultraviolet light absorbers ERCC5, ERCC4, ERCC2 PLA2G4B 4762/4885NPC1 3542/4885ALDH1A1 979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.